Skip to main content
    F

    FibroBiologics, Inc. Common Stock (FBLG)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.90
    -0.02 (-2.56%)

    Market Cap: $6.57M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    FibroBiologics, Inc. Common Stock (FBLG) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    FibroBiologics, Inc. Common Stock (FBLG) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, FibroBiologics, Inc. Common Stock reported EPS of -$2.60, below the -$0.63 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    50%(5/10)
    Avg Surprise
    -1.51%

    Upcoming Estimates

    Reports Feb 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.64
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    FBLG has an expected report date of Feb 22, 2027.

    Earnings History

    Of the 10 quarters below that had an estimate, FBLG beat 5, missed 3 and matched 2. The widest gap in the table came in the quarter ended Sep 30, 2026, when EPS landed 312.70% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$2.60-$0.63-$0.63 - -$0.63-312.70%MissN/A11 up, 0 downNov 13, 2026
    Jun 30, 2026-$0.66-$0.93-$0.93 - -$0.93+29.03%BeatN/A11 up, 0 downJul 31, 2026
    Mar 31, 2026-$1.33-$1.36-$1.40 - -$1.31+1.84%BeatN/A21 up, 0 downApr 30, 2026
    Dec 31, 2025-$0.60-$2.00-$2.00 - -$2.00+70.00%BeatN/A21 up, 1 downFeb 24, 2026
    Sep 30, 2025-$2.60-$2.30-$2.40 - -$2.20-13.04%MissN/A21 up, 0 downOct 31, 2025
    Jun 30, 2025-$0.12-$0.12-$0.12 - -$0.120.00%In line-120.0%21 up, 1 downJul 31, 2025
    Mar 31, 2025-$2.80-$2.50-$2.80 - -$2.20-12.00%MissN/A20 up, 0 downMay 14, 2025
    Dec 31, 2024-$0.09-$0.09N/A0.00%In lineN/A10 up, 0 downMar 27, 2025
    Sep 30, 2024-$0.20-$1.73N/A+88.44%BeatN/A10 up, 0 downNov 12, 2024
    Jun 30, 2024$0.60-$1.80N/A+133.33%BeatN/AN/AN/AAug 7, 2024
    Mar 31, 2024-$0.27N/AN/AN/AN/AN/AN/AN/AMay 14, 2024
    Last 11 quarters

    Annual EPS

    EPS for the fiscal year ended Jun 30, 2026 was -$5.19, after -$3.21 the year before. It was $0.33 for the year ended Jun 30, 2024, the oldest of the 3 fiscal years shown.

    Fiscal year endedEPSChange
    Jun 30, 2026-$5.19N/A
    Jun 30, 2025-$3.21-1072.7%
    Jun 30, 2024$0.33N/A

    Frequently Asked Questions About FBLG

    When is FibroBiologics, Inc. Common Stock's next earnings date?

    FibroBiologics, Inc. Common Stock's next earnings report is expected for Feb 22, 2027.

    Did FBLG beat earnings estimates last quarter?

    No. FibroBiologics, Inc. Common Stock reported EPS of -$2.60 for the quarter ended Sep 30, 2026, below the -$0.63 estimate by 312.70%.

    What EPS do analysts expect from FBLG next quarter?

    The consensus EPS estimate for FibroBiologics, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.64 from 3 analysts.

    How often does FBLG beat earnings estimates?

    FibroBiologics, Inc. Common Stock beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -29.61%.